Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Major Depressive Disorder
Related studies linked through entity extraction aliases.
Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE3
A 6 Week Study to Determine the Effectiveness of R228060 in Adult Subjects With Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE2
Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE3
Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Study Evaluating DVS-233 in Adult Outpatients With Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE3
Brain Regulation of Emotions in People With Depression and Anhedonia
- Status
- COMPLETED
- Phase
- N/A
Major Depressive Disorder Study In Adults
- Status
- COMPLETED
- Phase
- PHASE4
Treatment of Patients With Major Depressive Disorder With MK0869 (0869-062)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE3
Long Term Treatment of Patients With Major Depressive Disorder With MK0869 (0869-065)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE3
Dose Escalation, Double-Blind Treatment With Duloxetine Hydrochloride Once Daily Dosing for Evaluation of Safety in Major Depression
- Status
- COMPLETED
- Phase
- PHASE3
Open-Label Treatment With Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients With Major Depression
- Status
- COMPLETED
- Phase
- PHASE3
Treatment of Patients With Major Depressive Disorder With MK0869 (0869-073)
- Status
- COMPLETED
- Phase
- PHASE3
The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant Depression
- Status
- COMPLETED
- Phase
- PHASE3
Treatment of Patients With Major Depressive Disorder With MK0869 (0869-061)
- Status
- COMPLETED
- Phase
- PHASE3
Treatment of Patients With Major Depressive Disorder With MK0869 (0869-060)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE3
Treatment of Patients With Major Depressive Disorder With MK0869 (0869-068)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE3
Treatment of Patients With Major Depressive Disorder With MK0869 (0869-059)
- Status
- COMPLETED
- Phase
- PHASE3
Treatment of Patients With Major Depressive Disorder With MK0869 (0869-066)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE3
Treatment of Patients With Major Depressive Disorder With MK0869 (0869-063)
- Status
- COMPLETED
- Phase
- PHASE3